Pure Global AI
NCT06207474Completed

A Study on BReast Cancer Patient Care Using chAtbot and Video Education for Radiation Therapy (BRAVE)

Yonsei UniversityClinicalTrials.govother
Verified
Study focus
Disease/Condition
Breast Neoplasms
Drug/Device/Intervention
Video + Chatbot
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Yonsei University
Location
Seoul, South Korea
Timeline & enrollment
Phase
N/A
Start date
Apr 18, 2022
End date
Apr 18, 2023
Enrollment
148 participants
Primary outcome

APAIS(Amsterdam Preoperative Anxiety and Information Scale)

Summary

This randomized trial explored whether digital media (videos and chatbots) used for patient
 education could more effectively reduce anxiety in breast cancer patients during radiation
 therapy, compared to traditional paper-based methods. Post-surgery breast cancer patients
 scheduled for radiation therapy were assigned to groups receiving treatment information
 through different media combinations. The study aimed to assess whether these modern tools
 more effectively ease anxiety, thus potentially improving patient compliance and treatment
 experience.

ICD-10 classifications
Malignant neoplasm of breastMalignant neoplasm of breastMalignant neoplasm: Breast, unspecifiedBenign neoplasm of breastMalignant neoplasm: Central portion of breast
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06207474
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06207474 through Pure Global AI's free database. This phase not specified trial is sponsored by Yonsei University and is currently Completed. The study focuses on Breast Neoplasms. Target enrollment is 148 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.